Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-12-10
pubmed:abstractText
Hydroxyurea (HU) has been shown to increase the proportion of fetal haemoglobin (HbF) in most sickle cell patients. A low-dosage regimen increased total haemoglobin (Hb) levels in some thalassaemia intermedia patients by preferentially increasing beta-globin biosynthesis. To further characterize these apparent dose-dependent effects of HU, we examined erythroid cells exposed to HU (5-100 micro mol/l) in two-phase liquid culture. Low doses (from 5 to 25 micro mol/l) increased Hb levels by up to 2.7-fold, and a high dose (100 micro mol/l) increased Hb levels when added at d 3-6 of phase II, with no significant changes in response to HU during the late stage of phase II culture (> or = 9 d). HU exposure during d 0-3 of phase II culture increased the number of erythroid colonies to a maximum of fivefold at 5 micro mol/l HU. GATA-1 mRNA was downregulated at a high dose and GATA-2 was dose dependently upregulated over a lower dosage range. Treatment with 100 micro mol/l HU dramatically upregulated the death receptor DR-5, caspase 3, as determined by cDNA microarray analysis. In contrast, 10 micro mol/l HU modestly upregulated mRNA levels of the early growth response gene. Our results suggest that HU exerts concentration-dependent effects on HbF production and erythropoiesis and that these two effects are mediated by distinct molecular mechanisms.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Erythroid-Specific DNA-Binding..., http://linkedlifedata.com/resource/pubmed/chemical/GATA1 Transcription Factor, http://linkedlifedata.com/resource/pubmed/chemical/GATA1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/GATA2 Transcription Factor, http://linkedlifedata.com/resource/pubmed/chemical/GATA2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Globins, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyurea, http://linkedlifedata.com/resource/pubmed/chemical/Nucleic Acid Synthesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0007-1048
pubmed:author
pubmed:issnType
Print
pubmed:volume
119
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1098-105
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:12472594-Adult, pubmed-meshheading:12472594-Cell Culture Techniques, pubmed-meshheading:12472594-Cell Differentiation, pubmed-meshheading:12472594-Chromatography, High Pressure Liquid, pubmed-meshheading:12472594-Colony-Forming Units Assay, pubmed-meshheading:12472594-DNA-Binding Proteins, pubmed-meshheading:12472594-Dose-Response Relationship, Drug, pubmed-meshheading:12472594-Erythroid Precursor Cells, pubmed-meshheading:12472594-Erythroid-Specific DNA-Binding Factors, pubmed-meshheading:12472594-Erythropoiesis, pubmed-meshheading:12472594-GATA1 Transcription Factor, pubmed-meshheading:12472594-GATA2 Transcription Factor, pubmed-meshheading:12472594-Gene Expression Profiling, pubmed-meshheading:12472594-Gene Expression Regulation, pubmed-meshheading:12472594-Globins, pubmed-meshheading:12472594-Humans, pubmed-meshheading:12472594-Hydroxyurea, pubmed-meshheading:12472594-Nucleic Acid Synthesis Inhibitors, pubmed-meshheading:12472594-RNA, Messenger, pubmed-meshheading:12472594-Transcription Factors
pubmed:year
2002
pubmed:articleTitle
Hydroxyurea exerts bi-modal dose-dependent effects on erythropoiesis in human cultured erythroid cells via distinct pathways.
pubmed:affiliation
The Molecular and Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't